Literature DB >> 20938180

Evaluation of surgical outcome scores according to ISGPS definitions in patients undergoing pancreatic resection.

B C Knight1, A Kausar, M Manu, B A Ammori, D J Sherlock, D A O'Reilly.   

Abstract

AIMS: To evaluate the role of the Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity (POSSUM), the Portsmouth variant (p-POSSUM) and the Glasgow Prognostic Score (GPS) in predicting outcome after pancreatic surgery with reference to the International Study Group of Pancreatic Surgery (ISGPS) definitions of post-pancreatectomy complications.
METHODS: All consecutive patients undergoing major pancreatic resection over a 32- month period were included. POSSUM, p-POSSUM and GPS score were calculated for each patient and correlated against the observed mortality and morbidity using the ISGPS definitions.
RESULTS: The observed:expected ratios for POSSUM mortality, POSSUM morbidity and p-POSSUM mortality were 0.24 (p < 0.0001), 0.86 (p < 0.0001) and 0.79 (p = 0.09), respectively. POSSUM had a 'poor fit' with respect to predicting morbidity (χ(2) = 16.4, 8 d.f., p = 0.04). Multifactorial regression analysis revealed the GPS as an independent predictor of post-operative outcome (GPS 1, p = 0.03, OR 2.99, 95% CI 1.4-7.9, and GPS 2, p = 0.02, OR 4.3, 95% CI 1.8-15.5).
CONCLUSION: POSSUM has a limited role as an outcome score in pancreatic resection. The GPS may be a novel alternative to POSSUM as a pre-operative predictor of outcome.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20938180     DOI: 10.1159/000313693

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  7 in total

1.  Pre-operative cardiopulmonary exercise testing predicts adverse post-operative events and non-progression to adjuvant therapy after major pancreatic surgery.

Authors:  Vishnu V Chandrabalan; Donald C McMillan; Roger Carter; John Kinsella; Colin J McKay; C Ross Carter; Euan J Dickson
Journal:  HPB (Oxford)       Date:  2013-02-20       Impact factor: 3.647

2.  Assessing surgical quality: comparison of general and procedure-specific morbidity estimation models for the risk adjustment of pancreaticoduodenectomy outcomes.

Authors:  C Ansorge; P Lindström; L Strömmer; J Blomberg; L Lundell; A Andrén-Sandberg; M Del Chiaro; R Segersvärd
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

3.  Implementation of an enhanced recovery programme following pancreaticoduodenectomy.

Authors:  Nichola Robertson; Peter James Gallacher; Natalie Peel; O James Garden; Mark Duxbury; Kristoffer Lassen; Rowan W Parks
Journal:  HPB (Oxford)       Date:  2012-10       Impact factor: 3.647

4.  Risk Factors and a New Prediction Model for Pancreatic Fistula After Pancreaticoduodenectomy.

Authors:  Jia-Yu Zhang; Jia Huang; Su-Ya Zhao; Xin Liu; Zhen-Cheng Xiong; Zhi-Ying Yang
Journal:  Risk Manag Healthc Policy       Date:  2021-05-10

Review 5.  The accuracy of pre-operative (P)-POSSUM scoring and cardiopulmonary exercise testing in predicting morbidity and mortality after pancreatic and liver surgery: A systematic review.

Authors:  J Dutton; M Zardab; V J F De Braal; D Hariharan; N MacDonald; S Hallworth; R Hutchins; S Bhattacharya; A Abraham; H M Kocher; V S Yip
Journal:  Ann Med Surg (Lond)       Date:  2020-12-28

6.  Clinical Implication of Preoperative C-Reactive Protein/Albumin Ratio in Malignant Transformation of Intraductal Papillary Mucinous Neoplasm: A Propensity Score Analysis.

Authors:  Hirotsugu Maruyama; Kojiro Tanoue; Yuki Ishikawa-Kakiya; Masafumi Yamamura; Akira Higashimori; Masaki Ominami; Yuji Nadatani; Shusei Fukunaga; Koji Otani; Shuhei Hosomi; Fumio Tanaka; Noriko Kamata; Yasuaki Nagami; Koichi Taira; Go Ohira; Kenjiro Kimura; Ryosuke Amano; Yasuhiro Fujiwara
Journal:  Diagnostics (Basel)       Date:  2022-02-21

7.  Early Experience with a Hepatobiliary and Pancreatic Quality Improvement Program.

Authors:  Derek O'Reilly; Rachel Edmiston; Pooja Bijoor; Rahul Deshpande; Nicola de'Liguori Carino; Basil Ammori; David J Sherlock
Journal:  BMJ Qual Improv Rep       Date:  2013-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.